Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry Study
Mia-Louise Nielsen, Troels C Petersen, Lara Valeska Maul, et al.
Dermatology (Basel, Switzerland)
|
January 20, 2017
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry
Pierre Jungo, Julia-Tatjana Maul, Vahid Djamei, et al.
Nature Communications
|
December 18, 2024
Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases
Teofila Seremet, Jeremy Di Domizio, Antoine Girardin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
Niccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Advances in Therapy
|
May 8, 2020
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
Uta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
Acta Dermato-Venereologica
|
February 7, 2025
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
Ramtin Lichtenberger, Lara Valeska Maul, Ion Birkenmaier, et al.
Dermatology (Basel, Switzerland)
|
January 12, 2017
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT
Julia-Tatjana Maul, Vahid Djamei, Antonios G A Kolios, et al.
The British Journal of Dermatology
|
April 28, 2022
Biomarkers of disease progression in people with psoriasis: a scoping review
Ravi Ramessur, Mark Corbett, David Marshall, et al.
The British Journal of Dermatology
|
May 24, 2022
Biomarkers of systemic treatment response in people with psoriasis: a scoping review
Mark Corbett, Ravi Ramessur, David Marshall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 17, 2025
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
Franz J Legat, Shawn G Kwatra, Adam Reich, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry Study
Mia-Louise Nielsen, Troels C Petersen, Lara Valeska Maul, et al.
Dermatology (Basel, Switzerland)
|
January 20, 2017
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry
Pierre Jungo, Julia-Tatjana Maul, Vahid Djamei, et al.
Nature Communications
|
December 18, 2024
Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases
Teofila Seremet, Jeremy Di Domizio, Antoine Girardin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
Niccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Advances in Therapy
|
May 8, 2020
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
Uta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
Acta Dermato-Venereologica
|
February 7, 2025
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
Ramtin Lichtenberger, Lara Valeska Maul, Ion Birkenmaier, et al.
Dermatology (Basel, Switzerland)
|
January 12, 2017
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT
Julia-Tatjana Maul, Vahid Djamei, Antonios G A Kolios, et al.
The British Journal of Dermatology
|
April 28, 2022
Biomarkers of disease progression in people with psoriasis: a scoping review
Ravi Ramessur, Mark Corbett, David Marshall, et al.
The British Journal of Dermatology
|
May 24, 2022
Biomarkers of systemic treatment response in people with psoriasis: a scoping review
Mark Corbett, Ravi Ramessur, David Marshall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 17, 2025
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
Franz J Legat, Shawn G Kwatra, Adam Reich, et al.
Page
of 12